IL169178A0 - Tiotropium containing hfc solution formulations - Google Patents

Tiotropium containing hfc solution formulations

Info

Publication number
IL169178A0
IL169178A0 IL169178A IL16917805A IL169178A0 IL 169178 A0 IL169178 A0 IL 169178A0 IL 169178 A IL169178 A IL 169178A IL 16917805 A IL16917805 A IL 16917805A IL 169178 A0 IL169178 A0 IL 169178A0
Authority
IL
Israel
Prior art keywords
solution formulations
containing hfc
hfc solution
tiotropium containing
tiotropium
Prior art date
Application number
IL169178A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL169178A0 publication Critical patent/IL169178A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL169178A 2002-12-16 2005-06-15 Tiotropium containing hfc solution formulations IL169178A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02028238 2002-12-16
PCT/EP2003/013692 WO2004054580A1 (en) 2002-12-16 2003-12-04 Tiotropium containing hfc solution formulations

Publications (1)

Publication Number Publication Date
IL169178A0 true IL169178A0 (en) 2007-07-04

Family

ID=32524008

Family Applications (1)

Application Number Title Priority Date Filing Date
IL169178A IL169178A0 (en) 2002-12-16 2005-06-15 Tiotropium containing hfc solution formulations

Country Status (13)

Country Link
EP (1) EP1575588A1 (zh)
JP (1) JP2006510680A (zh)
KR (1) KR20050085650A (zh)
CN (1) CN1726038A (zh)
AU (1) AU2003303029A1 (zh)
BR (1) BR0317340A (zh)
CA (1) CA2510043A1 (zh)
IL (1) IL169178A0 (zh)
MX (1) MXPA05006383A (zh)
PL (1) PL375868A1 (zh)
RU (1) RU2005122444A (zh)
WO (1) WO2004054580A1 (zh)
ZA (1) ZA200503546B (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
CA2606549A1 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
RU2007144531A (ru) * 2005-05-02 2009-06-10 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Новые кристаллические формы тиотропийбромида
JP5086267B2 (ja) 2005-12-19 2012-11-28 シコール インコーポレイティド 臭化チオトロピウムの新規な形態およびそれを製造する方法
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
EP2201934A1 (en) 2008-12-23 2010-06-30 CHIESI FARMACEUTICI S.p.A. Tiotropium aerosol formulation products with improved chemical stability
GEP20166479B (en) 2009-12-23 2016-05-25 Chiesi Farma Spa Aerosol formulation for copd
CN102665679B (zh) 2009-12-23 2014-11-26 奇斯药制品公司 用于copd的联合治疗
GB201200525D0 (en) * 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
GB201200504D0 (en) 2011-12-19 2012-02-22 Teva Branded Pharmaceutical Prod R & D Inc An inhaler
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
US20150250713A1 (en) * 2012-10-23 2015-09-10 Cipla Limited Pharmaceutical Composition
DK2897588T3 (da) * 2013-11-22 2019-08-12 Teva Branded Pharmaceutical Products R&D Inc Inhalerbart lægemiddel
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
MY202069A (en) 2016-09-19 2024-03-31 Mexichem Fluor Sa De Cv Pharmaceutical composition
CN115252552A (zh) * 2016-09-19 2022-11-01 墨西哥氟石股份公司 药物组合物
US11260052B2 (en) 2016-09-19 2022-03-01 Mexichem Fluor S.A. De C.V. Pharmaceutical composition
CN113069417A (zh) * 2016-09-19 2021-07-06 墨西哥氟石股份公司 药物组合物
EP3515425B1 (en) 2016-09-19 2021-06-09 Mexichem Fluor S.A. de C.V. Pharmaceutical composition comprising salmeterol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284203B6 (cs) * 1992-12-09 1998-09-16 Boehringer Ingelheim Pharmaceuticals Inc. Tekutý aerosolový přípravek obsahující léčivo a způsob stabilisace tohoto prostředku
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

Also Published As

Publication number Publication date
PL375868A1 (en) 2005-12-12
ZA200503546B (en) 2006-10-25
BR0317340A (pt) 2005-11-08
CA2510043A1 (en) 2004-07-01
MXPA05006383A (es) 2005-08-29
EP1575588A1 (en) 2005-09-21
AU2003303029A1 (en) 2004-07-09
WO2004054580A1 (en) 2004-07-01
KR20050085650A (ko) 2005-08-29
JP2006510680A (ja) 2006-03-30
CN1726038A (zh) 2006-01-25
RU2005122444A (ru) 2007-01-27

Similar Documents

Publication Publication Date Title
ZA200503546B (en) Tiotropium containing HFC solution formulations
HK1207965A1 (zh) 包含甲基納曲酮的藥物配方
IL162642A0 (en) Formulations
IL172824A0 (en) Pharmaceutical formulations
GB0302671D0 (en) Pharmaceutical formulations
IL171942A0 (en) Compositions containing ecteinascidin-743
GB0303396D0 (en) Medicinal compounds
GB0319874D0 (en) Novel formulation
EP1694278A4 (en) GLP-1 PHARMACEUTICAL COMPOSITIONS
ZA200508984B (en) Antifoaming formulations
GB0323701D0 (en) Formulations
EP1503804A4 (en) RADIOPHARMACEUTICAL FORMULATIONS
GB0302672D0 (en) Pharmaceutical formulations
GB0325383D0 (en) Oral formulations
GB0316341D0 (en) Pharmaceutical formulations
GB0307765D0 (en) Tissue-adhesive formulations
AU2003264443A8 (en) Preparation for external use
IL174589A0 (en) Pharmaceutical compositions containing tetrahydrobiopterin
GB0214147D0 (en) Formulations
GB0316335D0 (en) Pharmaceutical formulations
SI1492513T1 (sl) HFA-suspenzijske formulacije, ki vsebujejo antiholinergik
GB0318871D0 (en) Tissue-adhesive formulations
GB0318503D0 (en) Formulations
GB0319551D0 (en) Formulations
GB0319549D0 (en) Formulations